drug
TRIJARDY XR
updated 5mo agoby Boehringer Ingelheim Corp
community read0 votes
🐶 often sniffed alongside
top 8- tagApproval192 co-mentions · 89 sources
- tagSmall Molecule96 co-mentions · 89 sources
- companyBoehringer Ingelheim Corp96 co-mentions · 89 sources
- drugSYNJARDY35 co-mentions · 35 sources
- drugempagliflozin26 co-mentions · 26 sources
- drugJARDIANCE26 co-mentions · 26 sources
- drug(empagliflozin + linagliptin)21 co-mentions · 21 sources
- drugGLYXAMBI21 co-mentions · 21 sources
all catalysts(0)
nothing on the calendar yet
Trials studying TRIJARDY XR
- phase2A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
- phase3EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- phase3A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
- phase2A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- phase2Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellitus
- phase3A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- phase2Empagliflozin in Patients With Cirrhosis and Ascites
- phase3EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that